447 related articles for article (PubMed ID: 31616439)
21. Fluorofenidone attenuates renal fibrosis by inhibiting the mtROS-NLRP3 pathway in a murine model of folic acid nephropathy.
Liao X; Jiang Y; Dai Q; Yu Y; Zhang Y; Hu G; Meng J; Xie Y; Peng Z; Tao L
Biochem Biophys Res Commun; 2021 Jan; 534():694-701. PubMed ID: 33220928
[TBL] [Abstract][Full Text] [Related]
22. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
Anders HJ; Suarez-Alvarez B; Grigorescu M; Foresto-Neto O; Steiger S; Desai J; Marschner JA; Honarpisheh M; Shi C; Jordan J; Müller L; Burzlaff N; Bäuerle T; Mulay SR
Kidney Int; 2018 Mar; 93(3):656-669. PubMed ID: 29241624
[TBL] [Abstract][Full Text] [Related]
23. Caspase-11 promotes NLRP3 inflammasome activation via the cleavage of pannexin1 in acute kidney disease.
Yin F; Zheng PQ; Zhao LQ; Wang YZ; Miao NJ; Zhou ZL; Cheng Q; Chen PP; Xie HY; Li JY; Ni JY; Zhou L; Zhang W; Wang XX; Liu J; Lu LM
Acta Pharmacol Sin; 2022 Jan; 43(1):86-95. PubMed ID: 33758356
[TBL] [Abstract][Full Text] [Related]
24. NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis.
Luan J; Zhang X; Wang S; Li Y; Fan J; Chen W; Zai W; Wang S; Wang Y; Chen M; Meng G; Ju D
Front Immunol; 2018; 9():758. PubMed ID: 29692782
[TBL] [Abstract][Full Text] [Related]
25. P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling.
Han SJ; Lovaszi M; Kim M; D'Agati V; Haskó G; Lee HT
FASEB J; 2020 Apr; 34(4):5465-5482. PubMed ID: 32086866
[TBL] [Abstract][Full Text] [Related]
26. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
27. NLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function.
Zhuang Y; Ding G; Zhao M; Bai M; Yang L; Ni J; Wang R; Jia Z; Huang S; Zhang A
J Biol Chem; 2014 Sep; 289(36):25101-11. PubMed ID: 25059664
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.
Cao JY; Zhou LT; Li ZL; Yang Y; Liu BC; Liu H
J Pharmacol Sci; 2020 Jul; 143(3):226-233. PubMed ID: 32446726
[TBL] [Abstract][Full Text] [Related]
29. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
30. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
31. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
[TBL] [Abstract][Full Text] [Related]
32. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice.
Ludwig-Portugall I; Bartok E; Dhana E; Evers BD; Primiano MJ; Hall JP; Franklin BS; Knolle PA; Hornung V; Hartmann G; Boor P; Latz E; Kurts C
Kidney Int; 2016 Sep; 90(3):525-39. PubMed ID: 27262364
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cell transplantation inhibited high salt-induced activation of the NLRP3 inflammasome in the renal medulla in Dahl S rats.
Zhu Q; Li XX; Wang W; Hu J; Li PL; Conley S; Li N
Am J Physiol Renal Physiol; 2016 Apr; 310(7):F621-F627. PubMed ID: 26764201
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
[TBL] [Abstract][Full Text] [Related]
36. Renoprotective effect of rosmarinic acid by inhibition of indoxyl sulfate-induced renal interstitial fibrosis via the NLRP3 inflammasome signaling.
Hung TW; Hsieh YH; Lee HL; Ting YH; Lin CL; Chao WW
Int Immunopharmacol; 2024 Jun; 135():112314. PubMed ID: 38788450
[TBL] [Abstract][Full Text] [Related]
37. Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.
Boini KM; Hussain T; Li PL; Koka S
Cell Physiol Biochem; 2017; 44(1):152-162. PubMed ID: 29130962
[TBL] [Abstract][Full Text] [Related]
38. Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway.
Yu Q; Zhang M; Qian L; Wen D; Wu G
Life Sci; 2019 May; 225():1-7. PubMed ID: 30935950
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
